Date: Tuesday 10 June 2025
Time: 13:00 – 14:00 BST
Location: Online
As the United States undergoes significant shifts in healthcare policy under the new administration, the ripple effects are being felt far beyond its borders. For the European pharmaceutical industry, these changes present a mix of uncertainty and opportunity.
This webinar explored:
- How evolving US policies are impacting European regulatory and market access strategies
- What challenges lie ahead
- How companies can adapt to maintain growth and global competitiveness.
We joined leading experts and industry voices as we unpacked the implications, forecasted emerging trends, and discussed strategic responses from a European perspective.
Speakers
- Steve Glass, Chief Executive Officer
- Prof. Matthias Schönermark, Chief Strategy Officer
- Dr. Alexander Natz, Secretary General
- Hilary Stiss, Senior Director, International Affairs
Kintiga (formerly MAP Patient Access, AxTalis & SKC) is Europe’s leading independent specialist pharmaceutical and biotechnology management consultancy. Our mission is to partner with health technology developers to elevate client capabilities and expand European market access.
We provide strategic consulting services to optimise market access, commercialisation, and regulatory success, ensuring innovative treatments reach more European patients faster.
Our varied webinar programme aims to shine a spotlight on key developments in the market access sphere and share actionable approaches to alleviate some of the pain points that health technology developers face in their everyday work.
